ZLD 16.7% 56.0¢ zelira therapeutics limited

Ann: Zelira Meets Primary Endpoints for Insomnia Trial, page-47

  1. 1,316 Posts.
    lightbulb Created with Sketch. 488
    Zelira’s primed to launch the world’s first clinically validated cannabis product for insomnia .*.

    Thank goodness for a statistically significant result !!!

    Thats a solid milestone, well done zelira.

    looking forward to

    letting the world's first clinically validated full spectrum medicinal marijuana product to treat insomnia filter through the market.

    a rich pipeline of products launched in comings months

    reporting on opiod and autism trials

    and ofcourse generating revenues

    well done to this now clinically validated, revenue generating global bio tech ... the market will recognise this soon enough.



    happy camper here.
    Last edited by 1234maze: 19/02/20
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.